Astex Pharmaceuticals Inc

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. Dot Compliance upgrades AI-powered life sciences eQMS system, Dottie AI The system utilises generative and predictive AI to streamline and optimise the quality management process for customers in the pharmaceutical, biotech and medical device...
  3. HOOKIPA Pharma begins non-binding discussions to acquire Poolbeg Pharma The two pharmaceutical companies may create a clinical-stage biopharmaceutical company focused on the development and commercialisation of next-generation immunotherapies
  4. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Research & Development

Third cancer drug success for Astex drug discovery collaboration

AstraZeneca’s Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) receives US FDA marketing approval for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations (PIK3CA, AKT1 or PTEN)
Regulatory

Urothelial cancer treatment gets breakthrough therapy designation

Astex continues to deliver in oncology as Erdafitinib, a potential new treatment for metastatic urothelial cancer, receives US FDA breakthrough therapy designation
Research & Development

Heptares joins consortium applying cryo-electron microscopy to structure-based drug discovery

Cryo-EM can reveal the structure of complex molecular assemblies to near atomic level
Finance

Otsuka Pharmaceutical to purchase Astex

Will pay around US$866m to strengthen cancer drug and central nervous system portfolios
Subscribe now